Comparative analysis of fetal chromosomal karyotype and microarray abnormalities in isolated and non-isolated nasal bone developmental ultrasound
PAN Lu, YUAN Huizhen, ZOU Yongyi, RAO Huihua, LIU Yanqiu
Medical Genetic Center of Jiangxi Maternal and Child Health Hospital,Jiangxi Provincial Key Laboratory of Birth Defect for Prevention and Control,Nanchang 330006,China
Abstract:Objective To explore the application of chromosomal karyotype and chromosomal microarray analysis (CMA) in prenatal diagnosis of fetuses with nasal bone loss or dysplasia. Methods We collected 166 cases of nasal bone absence or dysplasia in prenatal ultrasound screening in our hospital from January 2018 to May 2020. They were divided into isolated group and non-isolated group based on whether to combine other minor or structural anomalies. All pregnant women underwent amniotic cavity puncture, and we analyzed chromosomal G band and microarray in amniotic fluid samples to investigate the relationship between nasal bone loss or dysplasia and chromosomal abnormities. Results Among the 166 fetal amniotic fluid samples with nasal bone absence or dysplasia, 16 cases of abnormal karyotype were detected, with a rate of 9.6%. And 19 cases of abnormal CMA were detected, with a rate of 11.4%. In 137 cases of isolated nasal bone dysplasia, 6 cases were detected with abnormal chromosomal karyotype, with a rate of 4.4%. Among 29 cases of non-isolated abnormal nasal bone development, 10 cases were detected with abnormal chromosomal karyotype, with a rate of 34.5%. There were 7 (5.1% detection rate) and 12 cases (41.3% detection rate) of pathogenic copy number variation (CNVs) in CMA isolated group and non-isolated group, respectively. Conclusion Isolated fetal nasal bone development is abnormal in prenatal ultrasound screening, with the total incidence of chromosomal karyotype and CMA abnormalities up to 11.7% (16/137). The incidences in non-isolated fetal nasal bone development are higher. Prenatal diagnosis is recommended to guide subsequent eugenic intervention.
潘璐, 袁慧珍, 黄婷婷, 邹永毅, 饶慧华, 刘艳秋. 孤立性和非孤立性鼻骨发育超声异常胎儿染色体核型及微阵列异常的比较分析[J]. 中国生育健康杂志, 2023, 34(1): 66-70.
PAN Lu, YUAN Huizhen, ZOU Yongyi, RAO Huihua, LIU Yanqiu. Comparative analysis of fetal chromosomal karyotype and microarray abnormalities in isolated and non-isolated nasal bone developmental ultrasound. Chinese Journal of Reproductive Health, 2023, 34(1): 66-70.
1 王慧芳,王诗雅.鼻骨发育异常筛查胎儿染色体异常的临床价值.中国产前诊断杂志(电子版),2015,7:8-10. 2 Gautier M,Gueneret M,Plavonil C,et al.Normal Range of Fetal Nasal Bone Length during the Second Trimester in an Afro-Caribbean population and likelihood ratio for trisomy 21 of absent or hypoplastic nasal bone.Fetal Diagn Ther,2017,42:130-136. 3 Cicero S,Rembouskos G,Vandecruys H,et al.Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.Ultrasound Obstet Gynecol,2004,23:218-223. 4 Bethune M.Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome:thickened nuchal fold,echogenic bowel,shortened femur,shortened humerus,pyelectasis and absent or hypoplastic nasal bone.Australas Radiol,2007,51:218-225. 5 马涛,杨晓,岳军,等.妊娠中晚期超声软指标与胎儿染色体异常及其围生结局.实用妇产科杂志,2017,33:110-113. 6 Ting YH,Lao TT,Lau TK,et al.Isolated absent or hypoplastic nasal bone in the second trimester fetus:is amniocentesis necessary.J Matern Fetal Neonatal Med,2011,24:555-558. 7 钱晓婷,包凌云,黄安茜,等.孕中晚期胎儿鼻骨的超声评估在染色体异常诊断中的价值.温州医科大学学报,2019,49:507-511. 8 Cicero S,Curcio P,Papageorghiou A,et al.Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation:an observational study.Lancet,2001,358:1665-1667. 9 杨昕,韩瑾,甄理,等.胎儿鼻骨缺失或发育不良与染色体核型异常的关系——187例分析.中华围产医学杂志,2015,18:339-342. 10 Agathokleous M,Chaveeva P,Poon LC,et al.Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol,2013,41:247-261. 11 Lin CY,Wang PH,Yang MJ,et al.A case of 45,X/47,XYY mosaicism in a male fetus with a hypoplastic nasal bone.J Ultrasound Med,2015,34:353-354. 12 Kagan KO,Sonek J,Berg X,et al.Facial markers in second- and third-trimester fetuses with trisomy 18 or 13,triploidy or Turner syndrome.Ultrasound Obstet Gynecol,2015,46:60-65. 13 Dukhovny S,Wilkins-Haug L,Shipp TD,et al.Absent fetal nasal bone:what does it mean for the euploid fetus.J Ultrasound Med,2013,32:2131-2134. 14 刘丛丛,戚庆炜,蒋宇林,等.26例胎儿鼻骨发育异常的产前诊断结果分析.发育医学电子杂志,2020,8:34-41. 15 Levy B,Wapner R.Prenatal diagnosis by chromosomal microarray analysis.Fertil Steril,2018,109:201-212. 16 Ganapathi M,Nahum O,Levy B.Prenatal diagnosis using chromosomal SNP microarrays.Methods Mol Biol,2019,1885:187-205. 17 Lee CN,Lin SY,Lin CH,et al.Clinical utility of array comparative genomic hybridisation for prenatal diagnosis:a cohort study of 3171 pregnancies.BJOG,2012,119:614-625. 18 Shaffer LG,Dabell MP,Fisher AJ,et al.Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies.Prenat Diagn,2012,32:976-985. 19 Hillman SC,Pretlove S,Coomarasamy A,et al.Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis:a systematic review and meta-analysis.Ultrasound Obstet Gynecol,2011,37:6-14. 20 Breman A,Pursley AN,Hixson P,et al.Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature.Prenat Diagn,2012,32:351-361.